Based on the 15-minute chart for SciSparc, the RSI indicator has triggered an oversold signal, and the KDJ indicator has formed a golden cross at 08/14/2025 13:15. This suggests that the stock price has experienced a sharp decline and has fallen below the level of fundamental support, indicating a shift in momentum towards an upward trajectory and potentially leading to further price increases.
On August 14, 2025, at 13:15, SciSparc Ltd.'s (Nasdaq: SPRC) 15-minute chart triggered a significant shift in technical indicators. The Relative Strength Index (RSI) has indicated an oversold condition, while the KDJ indicator formed a golden cross, suggesting a potential reversal in the stock's downward trend. These indicators signal a shift in momentum towards an upward trajectory, which could lead to further price increases.
The RSI, a momentum oscillator, typically ranges from 0 to 100. An RSI reading below 30 is considered oversold, indicating that the stock may be undervalued and poised for a rebound. In this case, the RSI's oversold signal suggests that SciSparc's stock price has fallen below its fundamental support level, creating an opportunity for a price reversal.
The KDJ indicator, which combines the Moving Average Convergence Divergence (MACD) with the KDJ lines, has formed a golden cross. This occurs when the KDJ line crosses above the signal line, indicating a potential change in the stock's trend from bearish to bullish. This signal is often used by traders to anticipate a price increase.
These technical indicators are supported by SciSparc's recent collaboration with Clearmind Medicine Inc. (Nasdaq: CMND), which has led to significant advancements, including the publication of an international patent application under the Patent Cooperation Treaty (PCT) for a novel combination therapy targeting obesity and metabolic syndrome [1]. Despite these promising developments, the technical indicators suggest a bearish trend. However, the recent signals indicate a potential change in the stock's trajectory.
Investors should closely monitor these developments and consider the broader market context. While the company's recent performance has been robust, the technical indicators suggest a potential slowdown or reversal in the near term. For a more comprehensive analysis, investors should consider the broader market context and other fundamental indicators.
References:
[1] https://www.ainvest.com/news/scisparc-kdj-death-cross-triggers-bearish-marubozu-15-minute-chart-2508-79/
[2] https://www.globenewswire.com/news-release/2025/08/12/3132019/0/en/Cannabinoid-Clinical-Trial-Pipeline-Gains-Momentum-50-Companies-Lead-the-Charge-in-Pioneering-New-Treatments-DelveInsight.html
Comments
No comments yet